Antares Therapeutics
Founders
Adam Friedman - M.D., Ph.D, CEO
Founded
2025
Stage
Series A
Invested
2025
Status
Private
Lightspeed Team
Dr. Shelley Chu - Partner
Jonathan MacQuitty - Partner
Dr. Brenton Fargnoli - Partner
Ravi Mhatre - Partner & Co-Founder

Antares pushes scientific boundaries and challenges assumptions to unlock new possibilities for improving patients’ lives. We drive differentiation by integrating predictive and industry-leading small molecule technologies, precision targeting and a culture of ingenuity, led by a veteran team of drug hunters.

Antares Therapeutics
Fraction Fraction

Faction Ventures, LLC (“Faction”) and Lightspeed Management Company, L.L.C. (“Lightspeed”) are separate businesses that operate independently of each other. Faction is a registered investment adviser under the United States Investment Advisers Act of 1940, as amended. Faction advises its own fund(s) and does not advise any Lightspeed clients, and Lightspeed does not advise Faction or any of its clients. Lightspeed and Faction are parties to an agreement pursuant to which Lightspeed holds certain interests in Faction and the fund(s) Faction manages.

continue to the Faction Site